Michela Bartolini

Title(s)Postdoctoral Scholar - Research Associate
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

Collapse Bibliographic 
Collapse Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy? Curr Oncol Rep. 2024 Nov; 26(11):1489-1501. Airoldi M, Bartolini M, Fazio R, Farinatti S, Daprà V, Santoro A, Puccini A. PMID: 39392559.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  2. Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2- Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication. Oncologist. 2024 Jun 03; 29(6):484-492. Borroni RG, Bartolini M, Gaudio M, Jacobs F, Benvenuti C, Gerosa R, Tiberio P, Manara SAAM, Solferino A, Santoro A, De Sanctis R. PMID: 38242689; PMCID: PMC11145009.
    View in: PubMed   Mentions:    Fields:    Translation:Humans
  3. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence? Expert Opin Pharmacother. 2024 Mar; 25(4):371-382. Stucchi E, Bartolini M, Airoldi M, Fazio R, Daprà V, Mondello G, Prete MG, Puccini A, Santoro A. PMID: 38568032.
    View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
  4. Lynch Syndrome: From Multidisciplinary Management to Precision Prevention. Cancers (Basel). 2024 Feb 20; 16(5). Dal Buono A, Puccini A, Franchellucci G, Airoldi M, Bartolini M, Bianchi P, Santoro A, Repici A, Hassan C. PMID: 38473212; PMCID: PMC10930657.
    View in: PubMed   Mentions: 2  
  5. Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand? Int J Mol Sci. 2023 Jul 29; 24(15). Daprà V, Airoldi M, Bartolini M, Fazio R, Mondello G, Tronconi MC, Prete MG, D'Agostino G, Foppa C, Spinelli A, Puccini A, Santoro A. PMID: 37569532; PMCID: PMC10418822.
    View in: PubMed   Mentions: 3     Fields:    Translation:Humans
  6. Editorial: New therapeutic approaches in microsatellite stable colorectal cancer patients. Front Oncol. 2023; 13:1240963. Bartolini M, Seeber A, Puccini A. PMID: 37546398; PMCID: PMC10403228.
    View in: PubMed   Mentions:
Michela's Networks
Concepts (30)
Derived automatically from this person's publications.
_
Similar People (60)
People who share similar concepts with this person.
_
Same Department
Search Department
_